angiotensin ii has been researched along with Familial Combined Hyperlipidemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bröijersén, A; Ekholm, M; Jörneskog, G; Kahan, T; Wallén, NH | 3 |
3 other study(ies) available for angiotensin ii and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia.
Topics: Angiotensin II; Blood Pressure; Female; Fibrinolysis; Healthy Volunteers; Humans; Hyperlipidemia, Familial Combined; Male; Plasminogen Activator Inhibitor 1 | 2016 |
Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia.
Topics: Adult; Angiotensin II; Blood Flow Velocity; Blood Pressure; Case-Control Studies; Female; Heart Rate; Hemodynamics; Hot Temperature; Humans; Hyperemia; Hyperlipidemia, Familial Combined; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Regional Blood Flow; Skin; Skin Temperature; Time Factors; Vascular Resistance; Vasodilation | 2008 |
Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
Topics: Adult; Angiotensin II; Antithrombins; Case-Control Studies; Female; Fibrinolysis; Humans; Hyperlipidemia, Familial Combined; Inflammation; Infusions, Intravenous; Interleukin-6; Leukocyte Count; Male; Middle Aged; Peptide Fragments; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombin; Time Factors; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha | 2009 |